Clarity Financial LLC Gilead Sciences, Inc. Transaction History

Clarity Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$57.92 - $72.58 $180,536 - $226,231	-3,117 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$64.88 - $73.64 $202,230 - $229,535	3,117 New	3,117 $226,000
Q3 2021 Oct 20, 2021	SELL	$67.69 - $73.03 $209,365 - $225,881	-3,093 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $93,554 - $102,221	-1,474 Reduced 32.28%	3,093 $213,000
Q1 2021 May 19, 2021	BUY	$60.0 - $68.46 $274,020 - $312,656	4,567 New	4,567 $295,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Clarity Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Clarity Financial LLC with notifications on news.